Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer

Oral Oncology

Volumn 50, Issue 1, 2014, Pages 52-58

  Herman, Lauren C ^a,b   Chen, Lucy ^b   Garnett, Alexandra ^a   Feldman, Lawrence E ^b   Smith, Brett ^a   Weichselbaum, Ralph R ^a,b   Spiotto, Michael T ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

Head and neck cancer; Induction chemotherapy; Radiation therapy; TPF protocol

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; CREATININE; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMORBIDITY; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; THERAPY DELAY; TREATMENT DURATION; TREATMENT RESPONSE;

CARBOPLATIN-PACLITAXEL; CISPLATIN, 5-FLUOROURACIL; CT; DOCETAXEL, CISPLATIN, 5-FLUORURACIL; FFDM; FREEDOM FROM DISTANT METASTASIS; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HNSCC; INDUCTION CHEMOTHERAPY; KARNOFSKY PERFORMANCE STATUS; KPS; LOCOREGIONAL CONTROL; LRC; MULTIVARIATE ANALYSIS; MVA; OS; OVERALL SURVIVAL; PACLITAXEL, 5FU, HYDROXYUREA; PF; PFS; PROGRESSION FREE SURVIVAL; RADIATION THERAPY; RADIOTHERAPY; RT; THFX; TPF; TPF PROTOCOL; UNIVARIATE ANALYSIS; UVA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 84890547181     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.08.007     Document Type: Article

References (32)

1. K.K. Ang, A. Chen, W.J. Curran Jr, A.S. Garden, P.M. Harari, and B.A. Murphy Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN) Cancer. 118 23 2012 5783 5792
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991; 324(24): 1685-90.
3. J.H. Lorch, O. Goloubeva, R.I. Haddad, K. Cullen, N. Sarlis, and R. Tishler Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Lancet Oncol 12 2 Feb 2011 153 159
4. J.B. Vermorken, E. Remenar, C. van Herpen, T. Gorlia, R. Mesia, and M. Degardin Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 17 2007 1695 1704 (Pubitemid 350005151)
5. M.R. Posner, D.M. Hershock, C.R. Blajman, E. Mickiewicz, E. Winquist, and V. Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 17 2007 1705 1715 (Pubitemid 350005152)
6. R. Hitt, A. Lopez-Pousa, J. Martinez-Trufero, V. Escrig, J. Carles, and A. Rizo Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 34 2005 8636 8645 (Pubitemid 46211506)
7. J.L. Lefebvre, Y. Pointreau, F. Rolland, M. Alfonsi, A. Baudoux, and C. Sire Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study J Clin Oncol 31 7 2013 853 859
8. M. Airoldi, P. Gabriele, A.M. Gabriele, M. Garzaro, L. Raimondo, and F. Pedani Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma Cancer Chemother Pharmacol 67 5 2011 1027 1034
9. A. Argiris, P. Jayaram, and D. Pichardo Revisiting induction chemotherapy for head and neck cancer Oncology (Williston Park) 19 6 2005 759 770 (Pubitemid 41725396)
10. A.J. Cmelak, S. Li, M.A. Goldwasser, B. Murphy, M. Cannon, and H. Pinto Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399 J Clin Oncol. 25 25 2007 3971 3977 (Pubitemid 47477276)
11. A.J. Cmelak, B.A. Murphy, B. Burkey, S. Douglas, Y. Shyr, and J. Netterville Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial Head Neck 29 4 2007 315 324 (Pubitemid 46623496)
12. F.R. Dunphy, T.L. Dunleavy, B.R. Harrison, K.M. Trinkaus, H.J. Kim, and B.C. Stack Jr Et al. Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 an 1999 Cancer 91 5 2001 940 948
13. C. Fakhry, W.H. Westra, S. Li, A. Cmelak, J.A. Ridge, and H. Pinto Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 4 2008 261 269 (Pubitemid 351480538)
14. G. Fornari, E. Artusio, L. Mairone, M. Airoldi, G. Bongioannini, and E. Amasio Paclitaxel and carboplatin in neo-adjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma Tumori 88 6 2002 489 494 (Pubitemid 36193899)
15. J.D. Hainsworth, A.A. Meluch, S. McClurkan, J.R. Gray, S.L. Stroup, and H.A. Burris 3rd Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network Cancer J 8 4 2002 311 321
16. S.B. Hancock, G.A. Krempl, V. Canfield, C. Bogardus, K. Kojouri, and S.K. Kaneaster Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy Laryngoscope 118 8 2008 1357 1361
17. D.J. Haraf, F.R. Rosen, K. Stenson, A. Argiris, B.B. Mittal, and M.E. Witt Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer Clin Cancer Res 9 16 Pt 1 2003 5936 5943 (Pubitemid 38018079)
18. M.S. Kies, D.H. Boatright, G. Li, G. Blumenschein, and A.K. El-Naggar Brandon Gunn G, et al. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults Head Neck 34 9 2011 1255 1262
19. M.S. Kies, F.C. Holsinger, J.J. Lee, W.N. William Jr., B.S. Glisson, and H.Y. Lin Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial J Clin Oncol 28 1 2010 8 14
20. M. Machtay, D.I. Rosenthal, D. Hershock, H. Jones, S. Williamson, and M.J. Greenberg Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial J Clin Oncol 20 19 2002 3964 3971
21. M.T. Milano, E.E. Vokes, J. Kao, W. Jackson, M.A. List, and K.M. Stenson Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions Int J Oncol 28 5 2006 1141 1151
22. N.E. Ready, R. Rathore, T.T. Johnson, A. Nadeem, P. Chougule, and C. Ruhl Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck Am J Clin Oncol 35 1 2012 6 12
23. J.K. Salama, K.M. Stenson, E.O. Kistner, B.B. Mittal, A. Argiris, and M.E. Witt Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels Ann Oncol 19 10 2008 1787 1794
24. S. Semrau, F. Waldfahrer, M. Lell, R. Linke, G. Klautke, and T. Kuwert Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue Early results. Strahlenther Onkol 187 1 2011 15 22
25. D.M. Shin, B.S. Glisson, F.R. Khuri, S.M. Lippman, L. Ginsberg, and E. Diaz Jr Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck Cancer 95 2 2002 322 330 (Pubitemid 34787599)
26. G. Vlacich, R. Diaz, S.W. Thorpe, B.A. Murphy, W. Kirby, and R.J. Sinard Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy Oncologist. 17 5 2012 673 6781
27. E.E. Vokes, K. Stenson, F.R. Rosen, M.S. Kies, A.W. Rademaker, and M.E. Witt Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer J Clin Oncol 21 2 2003 320 326 (Pubitemid 46606162)
28. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383 (Pubitemid 17055592)
29. D.A. Karnofsky, and J. Burchenal The clinical evaluation of chemotherapeutic agents in cancer 1949 Columbia Univ Press
30. J.P. Pignon, A. le Maitre, E. Maillard, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 1 2009 4 14
31. A.A. Forastiere, H. Goepfert, M. Maor, T.F. Pajak, R. Weber, and W. Morrison Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 22 2003 2091 2098 (Pubitemid 37464533)
32. T.Y. Seiwert, D.J. Haraf, E.E. Cohen, E.A. Blair, K. Stenson, and J.K. Salama A randomized phase II trial of cetuximab-based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and neck cancer (HNC) J Clin Oncol 29 Suppl. 2011 [abstr 5519]